Mangoceuticals, Inc. (MGRX) is a publicly traded company in the Healthcare sector, operating within the Medical - Healthcare Information Services industry. The company is headquartered in Dallas, TX, United States. The current CEO is Jacob D. Cohen.
MGRX has IPO date of 2023-03-21, 3 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $3.93M.
Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc.
